WHAT SHARES TO BUY IN 2021: After a difficult twelve months on the financial markets, three top … After a bad year, many investors will be hoping for better luck in 2021. Will the rollout of a Covid vaccine trigger an economic recovery and a rebound in share prices, or is there more trouble to […]

How CRISPR Is Changing Cancer Research and Treatment Ever since scientists realized that changes in DNA cause cancer, they have been searching for an easy way to correct those changes by manipulating DNA. Although several methods of gene editing have been developed over the years, none has really fit the bill for a quick, easy, […]

‘I have nothing to lose except my life’ A woman with an incurable form of blood cancer is hoping that in the new year she will not need to continue begging the government to fund treatment that she says is keeping her alive. Lara Said, 52, has multiple myeloma, a cancer that forms in plasma […]

2019 Multiple Myeloma Symposium | Managing Bone Disease Andrew Yee, MD explores bone disease in multiple myeloma, describing the various types of bone complications and new treatments available.

Best Multiple Myeloma Therapies for Elderly Patients Best Therapies for Elderly Patients Dr. Rafat Abonour IMF Patient & Family Seminar 2019 Boca Raton, FL | March 16-17 Please subscribe to our channel! Subscribe to International Myeloma Foundation: http://bit.ly/XlUtPE Visit our website at: https://www.myeloma.org Find us online: Facebook: http://facebook.com/myeloma Google+: http://gplus.to/imfmyeloma IMF on twitter: @IMFMyeloma (http://twitter.com/imfmyeloma) […]

Amgen (NASDAQ:AMGN) Rating Increased to Sell at BidaskClub Amgen (NASDAQ:AMGN) was upgraded by research analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a research report issued to clients and investors on Friday, BidAskClub reports. Several other research analysts have also recently weighed in on the company. Truist upgraded Amgen from […]